Rayno Life Science Portfolio:Exelixis (EXEL) and Neogen (NEOG) Soar
Exelixis (EXEL) stock was up over 30% today to $6.14 on positive data from two experimental cancer drugs for prostate and ovarian cancer. The XL 184 drug showed promising results with castration-resistant prostate cancer (CRPC) achieving either partial or complete remission in 19/20 prostate...
Rayno SnowBlog: LaNina Advisory-Nat Gas Up on Cold Weather- Update
11/23/10 Nat Gas is approaching its mid-Sep highs as cold weather is forecasted to continue for the next 10-14 days. Today's high is $4.29 up from lows around $3.70 on Oct 25. The Jan.'11 Futures Contracts is at $4.39 Quotes & Charts with Indicators - Stocks Options Futures Forex - Traders...
Microfluidics (MFLU.OB) Revenues Down 9% but Value Play Intact
Microfluidics reported revenues of $4.1M for Q3 2010 ended Sep 30 a decrease of 9% or $500k compared to the same period of 2009. Excluding revenues of $1.3M attributed to machine production of the 2009 H1N1 Flu pandemic, revenues grew 29%.Unit sales increased to 144 units compared to 127 units...
Rayno Life Science Portfolio Update: BLUD,ILMN, NEOG,SQNM
Immucor (BLUD) stock was up 5.7% to $18.91 on news that the DOJ closed its anti-trust investigation. The stock hit a low in early October when it slashed guidance due to lower utility of blood transfusion services.The Company is a leader in automated blood transfusion systems but still faces...
Cardiovascular Systems (CSII) Gains Traction-Good Value Play
Cardiovascular Systems(CSII) is a medical device Company that focuses on interventional treatment for peripheral arterial disease(PAD). The primary products are the Diamondback 360 and the Predator 360, minimally invasive catheter systems for a range of plaque types in leg arteries.PAD...